Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence"

被引：0
|
作者：
Yang, Ju Dong [1 ]
Leise, Michael D. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 06期
关键词：
SOFOSBUVIR PLUS RIBAVIRIN; ADVANCED LIVER-DISEASE; LEDIPASVIR; INFECTION;
D O I：
10.1016/j.jhep.2017.08.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1357 / 1357
页数：1
相关论文
共 50 条
  • [21] Perspectives and challenges of interferon-free therapy for chronic hepatitis C
    Lange, Christian M.
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 583 - 592
  • [22] Quercetin: bioflavonoids as part of interferon-free hepatitis C therapy?
    Lu, Nu
    Khachatoorian, Ronik
    French, Samuel W.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (06) : 619 - 621
  • [23] Hepatitis C, Effectiveness and Safety of interferon-free Combination Therapy
    Krome, Susanne
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (05): : 422 - 422
  • [24] Interferon-Free Hepatitis C Therapy How Close Are We?
    Pockros, Paul J.
    DRUGS, 2012, 72 (14) : 1825 - 1831
  • [25] Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: fact or fiction?
    Liu, Chen-Hua
    Kao, Jia-Horng
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S192 - S195
  • [26] Advances in Interferon-Free Hepatitis C Therapy: 2014 and Beyond
    Sarkar, Souvik
    Lim, Joseph K.
    HEPATOLOGY, 2014, 59 (04) : 1641 - 1644
  • [27] Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
    Urbanowicz, Arkadiusz
    Zagozdzon, Radoslaw
    Ciszek, Michal
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (02) : 79 - 88
  • [28] Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
    Arkadiusz Urbanowicz
    Radosław Zagożdżon
    Michał Ciszek
    Archivum Immunologiae et Therapiae Experimentalis, 2019, 67 : 79 - 88
  • [29] Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
    Nagata, Hiroko
    Nakagawa, Mina
    Asahina, Yasuhiro
    Sato, Ayako
    Asano, Yu
    Tsunoda, Tomoyuki
    Miyoshi, Masato
    Kaneko, Shun
    Otani, Satoshi
    Kawai-Kitahata, Fukiko
    Murakawa, Miyako
    Nitta, Sayuri
    Itsui, Yasuhiro
    Azuma, Seishin
    Kakinuma, Sei
    Nouchi, Toshihiko
    Sakai, Hideki
    Tomita, Makoto
    Watanabe, Mamoru
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 933 - 939
  • [30] TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy
    Etsuko Iio
    Kentaro Matsuura
    Noritomo Shimada
    Masanori Atsukawa
    Norio Itokawa
    Hiroshi Abe
    Keizo Kato
    Koichi Takaguchi
    Tomonori Senoh
    Yuichiro Eguchi
    Hideyuki Nomura
    Kai Yoshizawa
    Jong-Hon Kang
    Takeshi Matsui
    Noboru Hirashima
    Atsunori Kusakabe
    Tomokatsu Miyaki
    Kei Fujiwara
    Kayoko Matsunami
    Susumu Tsutsumi
    Katsuhiko Iwakiri
    Yasuhito Tanaka
    Journal of Gastroenterology, 2019, 54 : 339 - 346
12345